PTP4

General Information


DRACP ID  DRACP00101

Peptide Name   PTP4

Sequence  FLKLLKKLAAKFLPTIICKISYKC

Sequence Length  24

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=13.71 ± 2.12 µg/ml MTT assay 96 h 1
PC-3 Prostate carcinoma Carcinoma IC50=18.63 ± 0.99 µg/ml MTT assay 96 h 1
Hep 3B Childhood hepatocellular carcinoma; Pediatric hepatocellular carcinoma Carcinoma IC50=18.18 ± 3.31 µg/ml MTT assay 96 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=18.10 ± 2.13 µg/ml MTT assay 96 h 1

Hemolytic Activity  Human RBCs: 45.17% hemolysis at 100 μg/ml

Normal (non-cancerous) Cytotoxicity  HEK293: IC50=26.15 ± 6.23 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00101

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C135H228N30O28S2

Absent amino acids  DEGHMNQRVW

Common amino acids  K

Mass  319405

Pl  10.59

Basic residues  6

Acidic residues  0

Hydrophobic residues  12

Net charge  6

Boman Index  1209

Hydrophobicity  78.75

Aliphatic Index  138.33

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1615

Absorbance 280nm  70.22

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 14499271

Title  In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines

Doi 10.1016/s0196-9781(03)00194-3

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  1004

CancerPPD ID  1012

CancerPPD ID  1020

CancerPPD ID  1028

CancerPPD ID  1036

DRACP is developed by Dr.Zheng's team.